Medication for Opioid Use Disorder During Pregnancy - Maternal and Infant Network to Understand Outcomes Associated with Use of Medication for Opioid Use Disorder During Pregnancy (MAT-LINK), 2014-2021
This report is the first to describe the system, presenting detailed information on funding, structure, data elements, and methods as well as findings from a surveillance evaluation. The findings presented in this report are limited to selected demographic characteristics of pregnant persons overall and by MOUD treatment status. Clinical and outcome data are not included because data collection and cleaning have not been completed; initial analyses of clinical and outcome data will begin in 2023.RESULTS: The MAT-LINK surveillance network gathered data on 5,541 reported pregnancies with a known pregnancy outcome during 2014...
Source: MMWR Surveill Summ - May 2, 2023 Category: Epidemiology Authors: Kathryn Miele Shin Y Kim Rachelle Jones Juneka H Rembert Elisha M Wachman Hira Shrestha Michelle L Henninger Teresa M Kimes Patrick D Schneider Vaseekaran Sivaloganathan Katherine A Sward Vikrant G Deshmukh Pilar M Sanjuan Jessie R Maxwell Neil S Seligman Source Type: research
Medication for Opioid Use Disorder During Pregnancy - Maternal and Infant Network to Understand Outcomes Associated with Use of Medication for Opioid Use Disorder During Pregnancy (MAT-LINK), 2014-2021
This report is the first to describe the system, presenting detailed information on funding, structure, data elements, and methods as well as findings from a surveillance evaluation. The findings presented in this report are limited to selected demographic characteristics of pregnant persons overall and by MOUD treatment status. Clinical and outcome data are not included because data collection and cleaning have not been completed; initial analyses of clinical and outcome data will begin in 2023.RESULTS: The MAT-LINK surveillance network gathered data on 5,541 reported pregnancies with a known pregnancy outcome during 2014...
Source: MMWR Surveill Summ - May 2, 2023 Category: Epidemiology Authors: Kathryn Miele Shin Y Kim Rachelle Jones Juneka H Rembert Elisha M Wachman Hira Shrestha Michelle L Henninger Teresa M Kimes Patrick D Schneider Vaseekaran Sivaloganathan Katherine A Sward Vikrant G Deshmukh Pilar M Sanjuan Jessie R Maxwell Neil S Seligman Source Type: research
Medication for Opioid Use Disorder During Pregnancy - Maternal and Infant Network to Understand Outcomes Associated with Use of Medication for Opioid Use Disorder During Pregnancy (MAT-LINK), 2014-2021
This report is the first to describe the system, presenting detailed information on funding, structure, data elements, and methods as well as findings from a surveillance evaluation. The findings presented in this report are limited to selected demographic characteristics of pregnant persons overall and by MOUD treatment status. Clinical and outcome data are not included because data collection and cleaning have not been completed; initial analyses of clinical and outcome data will begin in 2023.RESULTS: The MAT-LINK surveillance network gathered data on 5,541 reported pregnancies with a known pregnancy outcome during 2014...
Source: MMWR Surveill Summ - May 2, 2023 Category: Epidemiology Authors: Kathryn Miele Shin Y Kim Rachelle Jones Juneka H Rembert Elisha M Wachman Hira Shrestha Michelle L Henninger Teresa M Kimes Patrick D Schneider Vaseekaran Sivaloganathan Katherine A Sward Vikrant G Deshmukh Pilar M Sanjuan Jessie R Maxwell Neil S Seligman Source Type: research
Medication for Opioid Use Disorder During Pregnancy - Maternal and Infant Network to Understand Outcomes Associated with Use of Medication for Opioid Use Disorder During Pregnancy (MAT-LINK), 2014-2021
This report is the first to describe the system, presenting detailed information on funding, structure, data elements, and methods as well as findings from a surveillance evaluation. The findings presented in this report are limited to selected demographic characteristics of pregnant persons overall and by MOUD treatment status. Clinical and outcome data are not included because data collection and cleaning have not been completed; initial analyses of clinical and outcome data will begin in 2023.RESULTS: The MAT-LINK surveillance network gathered data on 5,541 reported pregnancies with a known pregnancy outcome during 2014...
Source: MMWR Surveill Summ - May 2, 2023 Category: Epidemiology Authors: Kathryn Miele Shin Y Kim Rachelle Jones Juneka H Rembert Elisha M Wachman Hira Shrestha Michelle L Henninger Teresa M Kimes Patrick D Schneider Vaseekaran Sivaloganathan Katherine A Sward Vikrant G Deshmukh Pilar M Sanjuan Jessie R Maxwell Neil S Seligman Source Type: research
Medication for Opioid Use Disorder During Pregnancy - Maternal and Infant Network to Understand Outcomes Associated with Use of Medication for Opioid Use Disorder During Pregnancy (MAT-LINK), 2014-2021
This report is the first to describe the system, presenting detailed information on funding, structure, data elements, and methods as well as findings from a surveillance evaluation. The findings presented in this report are limited to selected demographic characteristics of pregnant persons overall and by MOUD treatment status. Clinical and outcome data are not included because data collection and cleaning have not been completed; initial analyses of clinical and outcome data will begin in 2023.RESULTS: The MAT-LINK surveillance network gathered data on 5,541 reported pregnancies with a known pregnancy outcome during 2014...
Source: MMWR Surveill Summ - May 2, 2023 Category: Epidemiology Authors: Kathryn Miele Shin Y Kim Rachelle Jones Juneka H Rembert Elisha M Wachman Hira Shrestha Michelle L Henninger Teresa M Kimes Patrick D Schneider Vaseekaran Sivaloganathan Katherine A Sward Vikrant G Deshmukh Pilar M Sanjuan Jessie R Maxwell Neil S Seligman Source Type: research
Medication for Opioid Use Disorder During Pregnancy - Maternal and Infant Network to Understand Outcomes Associated with Use of Medication for Opioid Use Disorder During Pregnancy (MAT-LINK), 2014-2021
This report is the first to describe the system, presenting detailed information on funding, structure, data elements, and methods as well as findings from a surveillance evaluation. The findings presented in this report are limited to selected demographic characteristics of pregnant persons overall and by MOUD treatment status. Clinical and outcome data are not included because data collection and cleaning have not been completed; initial analyses of clinical and outcome data will begin in 2023.RESULTS: The MAT-LINK surveillance network gathered data on 5,541 reported pregnancies with a known pregnancy outcome during 2014...
Source: MMWR Surveill Summ - May 2, 2023 Category: Epidemiology Authors: Kathryn Miele Shin Y Kim Rachelle Jones Juneka H Rembert Elisha M Wachman Hira Shrestha Michelle L Henninger Teresa M Kimes Patrick D Schneider Vaseekaran Sivaloganathan Katherine A Sward Vikrant G Deshmukh Pilar M Sanjuan Jessie R Maxwell Neil S Seligman Source Type: research
Medication for Opioid Use Disorder During Pregnancy - Maternal and Infant Network to Understand Outcomes Associated with Use of Medication for Opioid Use Disorder During Pregnancy (MAT-LINK), 2014-2021
This report is the first to describe the system, presenting detailed information on funding, structure, data elements, and methods as well as findings from a surveillance evaluation. The findings presented in this report are limited to selected demographic characteristics of pregnant persons overall and by MOUD treatment status. Clinical and outcome data are not included because data collection and cleaning have not been completed; initial analyses of clinical and outcome data will begin in 2023.RESULTS: The MAT-LINK surveillance network gathered data on 5,541 reported pregnancies with a known pregnancy outcome during 2014...
Source: MMWR Surveill Summ - May 2, 2023 Category: Epidemiology Authors: Kathryn Miele Shin Y Kim Rachelle Jones Juneka H Rembert Elisha M Wachman Hira Shrestha Michelle L Henninger Teresa M Kimes Patrick D Schneider Vaseekaran Sivaloganathan Katherine A Sward Vikrant G Deshmukh Pilar M Sanjuan Jessie R Maxwell Neil S Seligman Source Type: research
Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 8 Years - Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2020
MMWR Surveill Summ. 2023 Mar 24;72(2):1-14. doi: 10.15585/mmwr.ss7202a1.ABSTRACTPROBLEM/CONDITION: Autism spectrum disorder (ASD).PERIOD COVERED: 2020.DESCRIPTION OF SYSTEM: The Autism and Developmental Disabilities Monitoring (ADDM) Network is an active surveillance program that provides estimates of the prevalence of ASD among children aged 8 years. In 2020, there were 11 ADDM Network sites across the United States (Arizona, Arkansas, California, Georgia, Maryland, Minnesota, Missouri, New Jersey, Tennessee, Utah, and Wisconsin). To ascertain ASD among children aged 8 years, ADDM Network staff review and abstract develop...
Source: MMWR Surveill Summ - March 23, 2023 Category: Epidemiology Authors: Matthew J Maenner Zachary Warren Ashley Robinson Williams Esther Amoakohene Amanda V Bakian Deborah A Bilder Maureen S Durkin Robert T Fitzgerald Sarah M Furnier Michelle M Hughes Christine M Ladd-Acosta Dedria McArthur Elise T Pas Angelica Salinas Alison Source Type: research
Early Identification of Autism Spectrum Disorder Among Children Aged 4 Years - Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2020
This report focuses on children aged 4 years in 2020 compared with children aged 8 years in 2020.RESULTS: For 2020, ASD prevalence among children aged 4 years varied across sites, from 12.7 per 1,000 children in Utah to 46.4 in California. The overall prevalence was 21.5 and was higher among boys than girls at every site. Compared with non-Hispanic White children, ASD prevalence was 1.8 times as high among Hispanic, 1.6 times as high among non-Hispanic Black, 1.4 times as high among Asian or Pacific Islander, and 1.2 times as high among multiracial children. Among the 58.3% of children aged 4 years with ASD and information...
Source: MMWR Surveill Summ - March 23, 2023 Category: Epidemiology Authors: Kelly A Shaw Deborah A Bilder Dedria McArthur Ashley Robinson Williams Esther Amoakohene Amanda V Bakian Maureen S Durkin Robert T Fitzgerald Sarah M Furnier Michelle M Hughes Elise T Pas Angelica Salinas Zachary Warren Susan Williams Amy Esler Andrea Grz Source Type: research
Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 8 Years - Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2020
MMWR Surveill Summ. 2023 Mar 24;72(2):1-14. doi: 10.15585/mmwr.ss7202a1.ABSTRACTPROBLEM/CONDITION: Autism spectrum disorder (ASD).PERIOD COVERED: 2020.DESCRIPTION OF SYSTEM: The Autism and Developmental Disabilities Monitoring (ADDM) Network is an active surveillance program that provides estimates of the prevalence of ASD among children aged 8 years. In 2020, there were 11 ADDM Network sites across the United States (Arizona, Arkansas, California, Georgia, Maryland, Minnesota, Missouri, New Jersey, Tennessee, Utah, and Wisconsin). To ascertain ASD among children aged 8 years, ADDM Network staff review and abstract develop...
Source: MMWR Surveill Summ - March 23, 2023 Category: Epidemiology Authors: Matthew J Maenner Zachary Warren Ashley Robinson Williams Esther Amoakohene Amanda V Bakian Deborah A Bilder Maureen S Durkin Robert T Fitzgerald Sarah M Furnier Michelle M Hughes Christine M Ladd-Acosta Dedria McArthur Elise T Pas Angelica Salinas Alison Source Type: research
Early Identification of Autism Spectrum Disorder Among Children Aged 4 Years - Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2020
This report focuses on children aged 4 years in 2020 compared with children aged 8 years in 2020.RESULTS: For 2020, ASD prevalence among children aged 4 years varied across sites, from 12.7 per 1,000 children in Utah to 46.4 in California. The overall prevalence was 21.5 and was higher among boys than girls at every site. Compared with non-Hispanic White children, ASD prevalence was 1.8 times as high among Hispanic, 1.6 times as high among non-Hispanic Black, 1.4 times as high among Asian or Pacific Islander, and 1.2 times as high among multiracial children. Among the 58.3% of children aged 4 years with ASD and information...
Source: MMWR Surveill Summ - March 23, 2023 Category: Epidemiology Authors: Kelly A Shaw Deborah A Bilder Dedria McArthur Ashley Robinson Williams Esther Amoakohene Amanda V Bakian Maureen S Durkin Robert T Fitzgerald Sarah M Furnier Michelle M Hughes Elise T Pas Angelica Salinas Zachary Warren Susan Williams Amy Esler Andrea Grz Source Type: research
Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 8 Years - Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2020
MMWR Surveill Summ. 2023 Mar 24;72(2):1-14. doi: 10.15585/mmwr.ss7202a1.ABSTRACTPROBLEM/CONDITION: Autism spectrum disorder (ASD).PERIOD COVERED: 2020.DESCRIPTION OF SYSTEM: The Autism and Developmental Disabilities Monitoring (ADDM) Network is an active surveillance program that provides estimates of the prevalence of ASD among children aged 8 years. In 2020, there were 11 ADDM Network sites across the United States (Arizona, Arkansas, California, Georgia, Maryland, Minnesota, Missouri, New Jersey, Tennessee, Utah, and Wisconsin). To ascertain ASD among children aged 8 years, ADDM Network staff review and abstract develop...
Source: MMWR Surveill Summ - March 23, 2023 Category: Epidemiology Authors: Matthew J Maenner Zachary Warren Ashley Robinson Williams Esther Amoakohene Amanda V Bakian Deborah A Bilder Maureen S Durkin Robert T Fitzgerald Sarah M Furnier Michelle M Hughes Christine M Ladd-Acosta Dedria McArthur Elise T Pas Angelica Salinas Alison Source Type: research
Early Identification of Autism Spectrum Disorder Among Children Aged 4 Years - Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2020
This report focuses on children aged 4 years in 2020 compared with children aged 8 years in 2020.RESULTS: For 2020, ASD prevalence among children aged 4 years varied across sites, from 12.7 per 1,000 children in Utah to 46.4 in California. The overall prevalence was 21.5 and was higher among boys than girls at every site. Compared with non-Hispanic White children, ASD prevalence was 1.8 times as high among Hispanic, 1.6 times as high among non-Hispanic Black, 1.4 times as high among Asian or Pacific Islander, and 1.2 times as high among multiracial children. Among the 58.3% of children aged 4 years with ASD and information...
Source: MMWR Surveill Summ - March 23, 2023 Category: Epidemiology Authors: Kelly A Shaw Deborah A Bilder Dedria McArthur Ashley Robinson Williams Esther Amoakohene Amanda V Bakian Maureen S Durkin Robert T Fitzgerald Sarah M Furnier Michelle M Hughes Elise T Pas Angelica Salinas Zachary Warren Susan Williams Amy Esler Andrea Grz Source Type: research
Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 8 Years - Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2020
MMWR Surveill Summ. 2023 Mar 24;72(2):1-14. doi: 10.15585/mmwr.ss7202a1.ABSTRACTPROBLEM/CONDITION: Autism spectrum disorder (ASD).PERIOD COVERED: 2020.DESCRIPTION OF SYSTEM: The Autism and Developmental Disabilities Monitoring (ADDM) Network is an active surveillance program that provides estimates of the prevalence of ASD among children aged 8 years. In 2020, there were 11 ADDM Network sites across the United States (Arizona, Arkansas, California, Georgia, Maryland, Minnesota, Missouri, New Jersey, Tennessee, Utah, and Wisconsin). To ascertain ASD among children aged 8 years, ADDM Network staff review and abstract develop...
Source: MMWR Surveill Summ - March 23, 2023 Category: Epidemiology Authors: Matthew J Maenner Zachary Warren Ashley Robinson Williams Esther Amoakohene Amanda V Bakian Deborah A Bilder Maureen S Durkin Robert T Fitzgerald Sarah M Furnier Michelle M Hughes Christine M Ladd-Acosta Dedria McArthur Elise T Pas Angelica Salinas Alison Source Type: research
Early Identification of Autism Spectrum Disorder Among Children Aged 4 Years - Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2020
This report focuses on children aged 4 years in 2020 compared with children aged 8 years in 2020.RESULTS: For 2020, ASD prevalence among children aged 4 years varied across sites, from 12.7 per 1,000 children in Utah to 46.4 in California. The overall prevalence was 21.5 and was higher among boys than girls at every site. Compared with non-Hispanic White children, ASD prevalence was 1.8 times as high among Hispanic, 1.6 times as high among non-Hispanic Black, 1.4 times as high among Asian or Pacific Islander, and 1.2 times as high among multiracial children. Among the 58.3% of children aged 4 years with ASD and information...
Source: MMWR Surveill Summ - March 23, 2023 Category: Epidemiology Authors: Kelly A Shaw Deborah A Bilder Dedria McArthur Ashley Robinson Williams Esther Amoakohene Amanda V Bakian Maureen S Durkin Robert T Fitzgerald Sarah M Furnier Michelle M Hughes Elise T Pas Angelica Salinas Zachary Warren Susan Williams Amy Esler Andrea Grz Source Type: research
